Rang	Name	Position
1	Mr. Andrew R. Saik	CFO & Treasurer
2	Ms. Angela M. Cacace Ph.D.	Chief Scientific Officer
3	Dr. Randy Teel Ph.D.	CEO, President & Director
4	Mr. David K. Loomis M.B.A.	VP & Chief Accounting Officer
5	Mr. Jeff Boyle	Vice President of Investor Relations
6	Mr. Jared M. Freedberg J.D.	General Counsel & Corporate Secretary
7	Mr. Steve Weiss	Senior VP & Chief Human Resources Officer
8	Mr. Paul McInulty	Senior Vice President of Regulatory Affairs
9	Ms. Kelly Page	Senior VP & Global Head of Oncology Strategy and Program Leadership

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	10,40%	56,68 Mio. USD
2	Vanguard Portfolio Management, LLC	5,95%	32,43 Mio. USD
3	D. E. Shaw & Co LP	5,35%	29,14 Mio. USD
4	Pfizer Inc	5,29%	28,83 Mio. USD
5	Vanguard Capital Management, LLC	4,11%	22,42 Mio. USD
6	Two Sigma Investments LLC	3,94%	21,46 Mio. USD
7	Armistice Capital, LLC	3,03%	16,49 Mio. USD
8	State Street Corp	2,80%	15,25 Mio. USD
9	Geode Capital Management, LLC	2,38%	12,98 Mio. USD
10	Jacobs Levy Equity Management, Inc.	2,20%	12,02 Mio. USD
11	Federated Hermes Inc	2,07%	11,31 Mio. USD
12	Qube Research & Technologies	1,84%	10,02 Mio. USD
13	Nextech Invest, Ltd.	1,72%	9,36 Mio. USD
14	Acadian Asset Management LLC	1,45%	7,92 Mio. USD
15	Vestal Point Capital LP	1,38%	7,55 Mio. USD
16	The Goldman Sachs Group Inc	1,16%	6,31 Mio. USD
17	Hillsdale Investment Management Inc.	1,15%	6,26 Mio. USD
18	TCG Crossover Management, LLC	1,08%	5,90 Mio. USD
19	Morgan Stanley - Brokerage Accounts	1,03%	5,63 Mio. USD
20	Dimensional Fund Advisors, Inc.	1,00%	5,46 Mio. USD